Advent Pharma Ltd. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was BDT 126.17 million compared to BDT 131.03 million a year ago. Net income was BDT 25.99 million compared to BDT 38.84 million a year ago. Basic earnings per share from continuing operations was BDT 0.2745 compared to BDT 0.4216 a year ago.
For the six months, sales was BDT 265.51 million compared to BDT 261.92 million a year ago. Net income was BDT 62.43 million compared to BDT 72.47 million a year ago. Basic earnings per share from continuing operations was BDT 0.6667 compared to BDT 0.7745 a year ago.